Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BRIEF-Valeant Pharmaceuticals and EyeGate enter into licensing agreement for EGP-437 combination product

By: Reuters: Company News
* Valeant Pharmaceuticals and EyeGate enter into licensing agreement for EGP-437 combination product in post-operative pain and inflammation in ocular surgery patients
Related Stocks:
Ab Corporate Bond ETF Valeant Pharmaceuticals International, Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.